Ex-Lannett Execs Face Derivative Suit Over Antitrust Probes
A shareholder of Lannett Co. Inc. has slapped several former executives at the generic-drug maker with a derivative lawsuit in Pennsylvania federal court, accusing them of orchestrating a damaging price-fixing scheme...To view the full article, register now.
Already a subscriber? Click here to view full article